JP2011528332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528332A5 JP2011528332A5 JP2011517954A JP2011517954A JP2011528332A5 JP 2011528332 A5 JP2011528332 A5 JP 2011528332A5 JP 2011517954 A JP2011517954 A JP 2011517954A JP 2011517954 A JP2011517954 A JP 2011517954A JP 2011528332 A5 JP2011528332 A5 JP 2011528332A5
- Authority
- JP
- Japan
- Prior art keywords
- human beta
- beta defensin
- composition
- seq
- body weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08160761 | 2008-07-18 | ||
| EP08160761.6 | 2008-07-18 | ||
| EP08162486.8 | 2008-08-15 | ||
| EP08162486 | 2008-08-15 | ||
| EP08163614.4 | 2008-09-03 | ||
| EP08163614 | 2008-09-03 | ||
| EP09160448 | 2009-05-15 | ||
| EP09160448.8 | 2009-05-15 | ||
| PCT/EP2009/059251 WO2010007165A2 (en) | 2008-07-18 | 2009-07-17 | Treatment of inflammatory diseases with mammal beta defensins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011528332A JP2011528332A (ja) | 2011-11-17 |
| JP2011528332A5 true JP2011528332A5 (enExample) | 2012-04-12 |
Family
ID=41445843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517954A Pending JP2011528332A (ja) | 2008-07-18 | 2009-07-17 | 哺乳動物ベータ・デフェンシンを用いた炎症性疾患の処置 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20100016232A1 (enExample) |
| EP (1) | EP2320929B1 (enExample) |
| JP (1) | JP2011528332A (enExample) |
| KR (2) | KR20110031962A (enExample) |
| CN (1) | CN102159232A (enExample) |
| AP (1) | AP2011005537A0 (enExample) |
| AR (1) | AR072524A1 (enExample) |
| AU (1) | AU2009272680A1 (enExample) |
| BR (1) | BRPI0915780A2 (enExample) |
| CA (1) | CA2730674A1 (enExample) |
| CL (1) | CL2011000098A1 (enExample) |
| EA (1) | EA201170218A1 (enExample) |
| IL (1) | IL210714A0 (enExample) |
| MX (1) | MX2011000569A (enExample) |
| NZ (1) | NZ590466A (enExample) |
| TW (1) | TW201004641A (enExample) |
| WO (1) | WO2010007165A2 (enExample) |
| ZA (1) | ZA201100462B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR072525A1 (es) * | 2008-07-18 | 2010-09-01 | Novozymes As | Tratamiento de artritis reumatoidea con beta defensinas de mamiferos. uso. metodo. |
| EP2320930A2 (en) | 2008-07-18 | 2011-05-18 | Novozymes Adenium Biotech A/S | Treatment of inflammatory bowel diseases with mammal beta defensins |
| US8858964B2 (en) | 2010-04-15 | 2014-10-14 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
| KR101320472B1 (ko) * | 2010-06-16 | 2013-10-23 | 주식회사 나이벡 | 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물 |
| US20140127310A1 (en) * | 2011-04-15 | 2014-05-08 | Marine Polymer Technologies, Inc. | Treatment of disease with poly-n-acetylglucosamine nanofibers |
| US9217021B2 (en) | 2011-07-08 | 2015-12-22 | Defensin Therapeutics Aps | Oral treatment of inflammatory bowel disease |
| WO2013026794A1 (en) | 2011-08-19 | 2013-02-28 | Novozymes | Novel immunomodulatory peptide |
| JP6151981B2 (ja) * | 2013-06-18 | 2017-06-21 | 一般社団法人健康科学リソースセンター | 関節リウマチ患者における生物学的製剤の有効性の予測方法 |
| JP2017525370A (ja) | 2014-08-21 | 2017-09-07 | ザ ジェネラル ホスピタル コーポレイション | 腫瘍壊死因子スーパーファミリーおよびｔｎｆ様リガンドムテインならびに腫瘍壊死因子スーパーファミリーおよびｔｎｆ様リガンドムテインを調製および使用する方法 |
| GB201603653D0 (en) * | 2016-03-02 | 2016-04-13 | Cambridge Entpr Ltd | Combination Therapy |
| KR102465341B1 (ko) | 2016-04-29 | 2022-11-09 | 디펜신 테라퓨틱스 에이피에스 | 간, 담관 및 췌장 장애의 치료 |
| EP3554532B1 (en) * | 2016-12-13 | 2024-09-25 | Defensin Therapeutics ApS | Hbd2 for use in the treatment of inflammatory conditions of the lungs |
| KR102631543B1 (ko) * | 2018-03-14 | 2024-02-01 | 서울대학교산학협력단 | 세포 투과능 및 근육 재생능을 가지는 이중 기능성 펩타이드 및 이의 용도 |
| KR102631542B1 (ko) * | 2018-03-14 | 2024-02-01 | 서울대학교산학협력단 | 염증 감소능 및 줄기세포로부터 연골세포로의 분화 촉진능을 가지는 이중 기능성 펩타이드 및 이의 용도 |
| WO2020046002A1 (ko) * | 2018-08-31 | 2020-03-05 | 주식회사 나이벡 | 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도 |
| KR102244161B1 (ko) | 2018-08-31 | 2021-04-26 | 주식회사 나이벡 | 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도 |
| EP4469600A1 (en) | 2022-01-28 | 2024-12-04 | Johnson & Johnson Consumer Inc. | Biomarkers predictive of atopic dermatitis |
| WO2023194839A1 (en) | 2022-04-04 | 2023-10-12 | Donnelly | Window of opportunity skin treatment regimen and composition for preventing the onset of or treating atopic dermatitis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7338936B2 (en) * | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| US20080194481A1 (en) * | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
| NZ540506A (en) * | 2002-12-19 | 2008-09-26 | Yitzchak Hillman | Disease treatment via antimicrobial peptide inhibitors |
| GB0514482D0 (en) * | 2005-07-14 | 2005-08-17 | Ares Trading Sa | Protein |
| WO2007081486A2 (en) * | 2005-12-15 | 2007-07-19 | Ventria Bioscience | Oral administration of defensins to treat intestinal diseases |
| EP2190457A1 (en) * | 2007-09-11 | 2010-06-02 | Mondobiotech Laboratories AG | Use of a defensin peptide as a therapeutic agent |
| AR072525A1 (es) * | 2008-07-18 | 2010-09-01 | Novozymes As | Tratamiento de artritis reumatoidea con beta defensinas de mamiferos. uso. metodo. |
| EP2320930A2 (en) * | 2008-07-18 | 2011-05-18 | Novozymes Adenium Biotech A/S | Treatment of inflammatory bowel diseases with mammal beta defensins |
-
2009
- 2009-07-17 AR ARP090102740A patent/AR072524A1/es not_active Application Discontinuation
- 2009-07-17 US US12/504,930 patent/US20100016232A1/en not_active Abandoned
- 2009-07-17 EP EP09780789.5A patent/EP2320929B1/en active Active
- 2009-07-17 NZ NZ590466A patent/NZ590466A/xx not_active IP Right Cessation
- 2009-07-17 KR KR1020117002473A patent/KR20110031962A/ko not_active Withdrawn
- 2009-07-17 MX MX2011000569A patent/MX2011000569A/es not_active Application Discontinuation
- 2009-07-17 CA CA2730674A patent/CA2730674A1/en not_active Abandoned
- 2009-07-17 AP AP2011005537A patent/AP2011005537A0/xx unknown
- 2009-07-17 WO PCT/EP2009/059251 patent/WO2010007165A2/en not_active Ceased
- 2009-07-17 AU AU2009272680A patent/AU2009272680A1/en not_active Abandoned
- 2009-07-17 KR KR1020117002950A patent/KR20110044863A/ko not_active Withdrawn
- 2009-07-17 BR BRPI0915780-8A patent/BRPI0915780A2/pt not_active IP Right Cessation
- 2009-07-17 CN CN2009801363423A patent/CN102159232A/zh active Pending
- 2009-07-17 EA EA201170218A patent/EA201170218A1/ru unknown
- 2009-07-17 JP JP2011517954A patent/JP2011528332A/ja active Pending
- 2009-07-20 TW TW098124404A patent/TW201004641A/zh unknown
-
2011
- 2011-01-17 CL CL2011000098A patent/CL2011000098A1/es unknown
- 2011-01-18 ZA ZA2011/00462A patent/ZA201100462B/en unknown
- 2011-01-18 IL IL210714A patent/IL210714A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528332A5 (enExample) | ||
| JP2014506321A5 (enExample) | ||
| NZ590466A (en) | Treatment of inflammatory diseases with mammal beta defensins | |
| JP2014527040A5 (enExample) | ||
| JP2011528333A5 (enExample) | ||
| JP2010166916A5 (enExample) | ||
| JP2010505418A5 (enExample) | ||
| JP2013529647A5 (enExample) | ||
| JP2012518420A5 (enExample) | ||
| HRP20171176T1 (hr) | C5ar antagonisti | |
| JP2014516945A5 (enExample) | ||
| EP2824111A3 (en) | Anti-C5A Antibodies and Methods for Using the Antibodies | |
| JP2011225596A5 (enExample) | ||
| HRP20220250T1 (hr) | Modificirani nukleozidi, nukleotidi i nukleinske kiseline, te njihove uporabe | |
| MX2010001400A (es) | Metodo para tratar enfermedades mediadas cxcr3 usando piperazinas heterociclicas sustituidas. | |
| JP2010162017A5 (enExample) | ||
| JP2012509687A5 (enExample) | ||
| BR112014015142A2 (pt) | di-hidropirimidinoisoquinolinonas e composições farmacêuticas das mesmas para o tratamento de distúrbios inflamatórios | |
| JP2015517488A5 (enExample) | ||
| JP2014510082A5 (enExample) | ||
| JP2010515682A5 (enExample) | ||
| WO2013048214A3 (en) | Novel heterocyclic derivatives and their uses | |
| WO2012038980A3 (en) | Fused tricyclic compounds as adenosine receptor antagonist | |
| JP2013543499A5 (enExample) | ||
| JP2015524413A5 (enExample) |